Warty Dyskeratoma as a Cutaneous Horn of the Mons Pubis.
V. Lora,A. Scarabello,C. Cota
DOI: https://doi.org/10.1097/DAD.0000000000000262
2015-10-01
American Journal of Dermatopathology
Abstract:REFERENCES 1. Shan SJ, Guo Y. Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site. Am J Dermatopathol. 2014;36: 510–512. 2. Kim D, MacConell L, Zhuang D, et al. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care. 2007;30:1487–1493. 3. Nikfar S, Abdollahi M, Salari P. The efficacy and tolerability of exenatide in comparison to placebo; a systematic review and metaanalysis of randomized clinical trials. J Pharm Pharm Sci. 2012;15:1–30. 4. DeYoung MB, MacConell L, Sarin V, et al. Encapsulation of exenatide in poly-(D,Llactide-co-glycolide) microspheres produced an investigational longacting once-weekly formulation for type 2 diabetes. Diabetes Technol Ther. 2011;13:1145–1154. 5. Gentilella R, Bianchi C, Rossi A, et al. Exenatide: a review from pharmacology to clinical practice. Diabetes Obes Metab. 2009;11: 544–556. 6. Boysen NC, Stone MS. Eosinophil-rich granulomatous panniculitis caused by exenatide injection. J Cutan Pathol. 2014;41:63–65. 7. Sanmartín O, Requena C, Requena L. Factitial panniculitis. Dermatol Clin. 2008;26: 519–527. 8. Requena L, Requena C, Christensen L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011; 64:1–34. 9. Huh SY, Cho S, Kim KH, et al. A case of complication after Matridex injection. Ann Dermatol. 2010;22:81–84. 10. Schuller-Petrovic S, Pavlovic MD, Schuller SS, et al. Early granulomatous foreign body reactions to a novel alginate dermail filler: the system’s failure? J Eur Acad Dermatol Venereol. 2013; 27:121–123.